Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: AngioDynamics

This article was originally published in The Gray Sheet

Executive Summary

AngioDynamics: Wholly-owned E-Z-EM subsidiary gains 510(k) clearance for its Transjugular Access Set catheter system designed for minimally invasive liver operations such as TIPS (transjugular intrahepatic portal shunt) procedures. The system consists of a series of coaxial catheters and needles "which will cause less damage to other liver structures such as the bile duct as the physician establishes a pathway between the hepatic and portal veins," AngioDynamics President Eamonn Hobbs says in a June 17 release. The firm also is in the process of designing the AngioStent for malignant bile duct obstructions; the stent already is being sold outside the U.S. for cardiovascular indications...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel